4 results
Primary objective: to assess the correlation and agreement between the new TB technique and the conventional SB online technique with constant expiratory flow.Secondary objective: to investigate the reproducibility of this new technique.
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD ascompared with placebo in patients with mild AD dementia.
To test whether the proportion of patients in remission during the last 6 months of follow up is higher for a T2T strategy compared to a T2S stop strategy.
The aim is to see whether intradialytic parenteral nutrition is an efective treatment against the loss of muscle mass